JPS6313433B2 - - Google Patents

Info

Publication number
JPS6313433B2
JPS6313433B2 JP56094002A JP9400281A JPS6313433B2 JP S6313433 B2 JPS6313433 B2 JP S6313433B2 JP 56094002 A JP56094002 A JP 56094002A JP 9400281 A JP9400281 A JP 9400281A JP S6313433 B2 JPS6313433 B2 JP S6313433B2
Authority
JP
Japan
Prior art keywords
add
added
salt
residue
under reduced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP56094002A
Other languages
English (en)
Japanese (ja)
Other versions
JPS57209270A (en
Inventor
Sadao Tanaka
Kyonori Kuromaru
Yasuo Fujimura
Isao Matsunaga
Noriko Obata
Junichiro Aono
Yoshikazu Hinohara
Hideki Nakano
Masafumi Fukushima
Hiroyuki Nahata
Kazunari Sakai
Shunichi Hata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Priority to JP56094002A priority Critical patent/JPS57209270A/ja
Priority to AT0558581A priority patent/AT377496B/de
Priority to GB08215345A priority patent/GB2102412B/en
Priority to CA000404054A priority patent/CA1235120A/en
Priority to ZA823779A priority patent/ZA823779B/xx
Priority to IL65954A priority patent/IL65954A/xx
Priority to MX193189A priority patent/MX155724A/es
Priority to IT67772/82A priority patent/IT1157053B/it
Priority to MX010799A priority patent/MX171888B/es
Priority to NO821997A priority patent/NO156408C/no
Priority to FI822171A priority patent/FI75804C/fi
Priority to SU823450352A priority patent/SU1316556A3/ru
Priority to BE0/208378A priority patent/BE893553A/fr
Priority to CH3751/82A priority patent/CH651825A5/de
Priority to HU821976A priority patent/HU188177B/hu
Priority to DK273082A priority patent/DK156054C/da
Priority to NL8202472A priority patent/NL193282C/nl
Priority to PT75076A priority patent/PT75076B/pt
Priority to ES513277A priority patent/ES8307216A1/es
Priority to DE19823222779 priority patent/DE3222779A1/de
Priority to SE8203814A priority patent/SE453595B/sv
Priority to KR8202740A priority patent/KR890000769B1/ko
Priority to FR8210796A priority patent/FR2508040B1/fr
Priority to AT0238582A priority patent/AT390619B/de
Priority to SU823514502A priority patent/SU1272982A3/ru
Publication of JPS57209270A publication Critical patent/JPS57209270A/ja
Priority to ES520582A priority patent/ES8403868A1/es
Priority to AT0362883A priority patent/AT386603B/de
Publication of JPS6313433B2 publication Critical patent/JPS6313433B2/ja
Priority to KR1019880015389A priority patent/KR890000770B1/ko
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D209/20—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals substituted additionally by nitrogen atoms, e.g. tryptophane
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01D—MEASURING NOT SPECIALLY ADAPTED FOR A SPECIFIC VARIABLE; ARRANGEMENTS FOR MEASURING TWO OR MORE VARIABLES NOT COVERED IN A SINGLE OTHER SUBCLASS; TARIFF METERING APPARATUS; MEASURING OR TESTING NOT OTHERWISE PROVIDED FOR
    • G01D2205/00—Indexing scheme relating to details of means for transferring or converting the output of a sensing member
    • G01D2205/70—Position sensors comprising a moving target with particular shapes, e.g. of soft magnetic targets
    • G01D2205/77—Specific profiles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
JP56094002A 1981-06-19 1981-06-19 Proline derivative Granted JPS57209270A (en)

Priority Applications (28)

Application Number Priority Date Filing Date Title
JP56094002A JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative
AT0558581A AT377496B (de) 1981-06-19 1981-12-29 Vorrichtung zum anwickeln einer warenbahn auf eine neu eingelegte wickelhuelse in einer doppeltragwalzen-wickelmaschine
GB08215345A GB2102412B (en) 1981-06-19 1982-05-26 Proline derivatives and process for producing the same
CA000404054A CA1235120A (en) 1981-06-19 1982-05-28 Proline derivatives and process for producing the same
ZA823779A ZA823779B (en) 1981-06-19 1982-05-28 Proline derivatives and process for producing the same
IL65954A IL65954A (en) 1981-06-19 1982-06-02 Proline derivatives and process for producing them
MX193189A MX155724A (es) 1981-06-19 1982-06-16 Procedimiento para la preparacion de derivados de prolina
IT67772/82A IT1157053B (it) 1981-06-19 1982-06-16 Derivati della prolina e procedimento per la loro preparazione
MX010799A MX171888B (es) 1981-06-19 1982-06-16 Procedimiento para la preparacion de derivados de prolina
NO821997A NO156408C (no) 1981-06-19 1982-06-16 AnalogifremgangsmŸte for fremstilling av terapeutisk aktive l-prolinderivater.
FI822171A FI75804C (fi) 1981-06-19 1982-06-16 Foerfarande foer framstaellning av terapeutiskt aktivt prolinderivat.
SU823450352A SU1316556A3 (ru) 1981-06-19 1982-06-16 Способ получени производных пролина или их фармацевтически приемлемых солей
DK273082A DK156054C (da) 1981-06-19 1982-06-17 Analogifremgangsmaade til fremstilling af n-(3-acylthio-2-methylpropanoyl)-prolinforbindelser eller salte heraf
CH3751/82A CH651825A5 (de) 1981-06-19 1982-06-17 Prolinderivate sowie verfahren fuer ihre herstellung.
HU821976A HU188177B (en) 1981-06-19 1982-06-17 Process for producing new proline derivatives
BE0/208378A BE893553A (fr) 1981-06-19 1982-06-17 Derives de la proline et procede pour les preparer
NL8202472A NL193282C (nl) 1981-06-19 1982-06-18 Bloeddrukverlagend prolinederivaat en werkwijze voor het bereiden van een bloeddrukverlagend geneesmiddel.
PT75076A PT75076B (en) 1981-06-19 1982-06-18 Proline derivatives and process for producing the same
ES513277A ES8307216A1 (es) 1981-06-19 1982-06-18 Un procedimiento para producir derivados de prolina.
DE19823222779 DE3222779A1 (de) 1981-06-19 1982-06-18 Prolinderivate und verfahren zu deren herstellung
SE8203814A SE453595B (sv) 1981-06-19 1982-06-18 Prolinderivat
KR8202740A KR890000769B1 (ko) 1981-06-19 1982-06-19 프롤린 유도체의 제법
FR8210796A FR2508040B1 (fr) 1981-06-19 1982-06-21 Derives de proline, leur procede de preparation et medicament les contenant
AT0238582A AT390619B (de) 1981-06-19 1982-06-21 Verfahren zur herstellung von neuen prolinderivaten
SU823514502A SU1272982A3 (ru) 1981-06-19 1982-11-25 Способ получени производных пролина или их фармацевтически приемлемых солей
ES520582A ES8403868A1 (es) 1981-06-19 1983-03-14 Un procedimiento para producir derivados de prolina.
AT0362883A AT386603B (de) 1981-06-19 1983-10-11 Verfahren zur herstellung von neuen prolinderivaten
KR1019880015389A KR890000770B1 (ko) 1981-06-19 1988-11-22 프롤린 유도체의 제법

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP56094002A JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP62063596A Division JPS6345252A (ja) 1987-03-18 1987-03-18 プロリン誘導体

Publications (2)

Publication Number Publication Date
JPS57209270A JPS57209270A (en) 1982-12-22
JPS6313433B2 true JPS6313433B2 (cg-RX-API-DMAC10.html) 1988-03-25

Family

ID=14098203

Family Applications (1)

Application Number Title Priority Date Filing Date
JP56094002A Granted JPS57209270A (en) 1981-06-19 1981-06-19 Proline derivative

Country Status (5)

Country Link
JP (1) JPS57209270A (cg-RX-API-DMAC10.html)
AT (1) AT390619B (cg-RX-API-DMAC10.html)
BE (1) BE893553A (cg-RX-API-DMAC10.html)
SU (1) SU1272982A3 (cg-RX-API-DMAC10.html)
ZA (1) ZA823779B (cg-RX-API-DMAC10.html)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5614547A (en) * 1995-06-07 1997-03-25 Guilford Pharmaceuticals Inc. Small molecule inhibitors of rotamase enzyme
RU2269514C9 (ru) * 1995-06-07 2006-05-27 Джи-Пи-Ай Эн-Ай-Эл Холдингз, Инк. Ингибиторы ферментативной активности ротамазы, являющиеся малыми молекулами
CN1572882A (zh) * 1999-10-28 2005-02-02 三共株式会社 苯甲脒衍生物
AU2003250483A1 (en) 2002-08-19 2004-03-11 Pfizer Products Inc. Combination therapy for hyperproliferative diseases
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
ES2382009T3 (es) 2006-12-01 2012-06-04 Bristol-Myers Squibb Company Derivados de N-((3-bencil)-2,2-(bis-fenil-)-propan-1-amina como inhibidores de CETP para el tratamiento de aterosclerosis y enfermedades cardiovasculares
BR112015026513A2 (pt) 2013-04-17 2017-07-25 Pfizer derivados de n-piperidin-3-ilbenzamida para tratar as doenças cardiovasculares
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
FI3911648T3 (fi) 2019-01-18 2025-01-10 Astrazeneca Ab 6'-[[[(1s,3s)-3-[[5-(difluorometoksi)-2-pyrimidinyyli]amino]syklopentyyli]amino][1(2h),3'-bipyridin]-2-oni pcsk9:n estäjänä ja menetelmät sen käyttöön
CN115819270B (zh) * 2021-09-17 2025-03-21 洛阳中科生物芯片技术有限公司 金刚烷胺半抗原、金刚烷胺抗原、制备方法以及金刚烷胺单克隆抗体及金刚烷胺检测试剂盒

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR73585B (cg-RX-API-DMAC10.html) * 1978-09-11 1984-03-26 Univ Miami
ZA802420B (en) * 1979-05-18 1981-04-29 Squibb & Sons Inc Aminoacyl derivatives of mercaptoacyl amino acids
PT70158A1 (en) * 1980-03-03 1982-03-01 Univ Miami Process for preparing anti-hypertensive agents

Also Published As

Publication number Publication date
BE893553A (fr) 1982-12-17
SU1272982A3 (ru) 1986-11-23
JPS57209270A (en) 1982-12-22
ATA238582A (de) 1989-11-15
ZA823779B (en) 1984-01-25
AT390619B (de) 1990-06-11

Similar Documents

Publication Publication Date Title
US4256751A (en) Tetrahydroisoquinoline derivatives
EP0184550B1 (de) 5-Amino-4-hydroxyvalerylamid-Derivate
CA1230114A (en) Nitroxyl compounds, process for their preparation, and diagnostic media containing same
JPS6059226B2 (ja) プロリン誘導体および関連化合物
WO1993009135A1 (en) Peptides inhibiting il-1 beta release
JP2006056894A (ja) 置換イソキノリン−３−カルボキサミド、その製法および薬剤としてのその使用
EP0236734A2 (de) Durch schwefelhaltigen Gruppen substituierte 5-Amino-4-hydroxyvalerylderivate
FR2620711A1 (fr) Phosphinylcycloalkylcarbonyl et phosphinylcycloalcenylcarbonyl dipeptides a action therapeutique
JPH03386B2 (cg-RX-API-DMAC10.html)
JPS6313433B2 (cg-RX-API-DMAC10.html)
WO1991016337A1 (fr) Derive de glutathion a substitution-s-(acide gras inferieur)
HUT52525A (en) Process for producing retroviral proteaz-inhibitors and pharmaceutical compositions containing them as active components
GB2032433A (en) Cysteine derivatives
KR880002594B1 (ko) 트리펲타이드를 함유한 n-카르복시알킬프롤린을 제조하는 방법
SU1316556A3 (ru) Способ получени производных пролина или их фармацевтически приемлемых солей
DE69503905T2 (de) Peptidderivate mit metallopeptidasehemmender aktivität
DE69614508T2 (de) Thiol derivate mit metallopeptidase inhibierender aktivitat
SU1219587A1 (ru) Циклические аналоги каллидина и других пахикининов,обладающие пролонгированным гипотензивным действием в сочетании с низкой или полностью отсутствующей миотропной активностью
JPH02503006A (ja) 医薬作用を有するプリン誘導体
JP2002511451A (ja) アザシクロアルカン誘導体、その製造及び治療上の使用
IE65539B1 (en) Trifluoromethyl mercaptan and mercaptoacyl derivatives and method of using same
JP2974862B2 (ja) 新規１―チア―４，６―ジアザスピロ〔４．４〕ノナン誘導体およびその製法
JPS62132846A (ja) ４−アミノブタン酸誘導体及びその製法
CH434286A (de) Verfahren zur Herstellung eines neuen Hendekapeptids
KR890000770B1 (ko) 프롤린 유도체의 제법